Episode #3, May 2021
Lipid Leaders is a feature of the VESL community where we highlight the important work of researchers in the Canadian lipid and cardiovascular community. New interviews will be released bi-weekly. View archived Lipid Leaders interviews at veslcommunity.org/lipid-leaders.
In this episode of Lipid Leaders, Dr. Robert Hegele speaks with Dr. Liam Brunham
, MD, PhD, FRCPC, Associate Professor in the Department of Medicine at the University of British Columbia and Medical Lead of the Healthy Heart Program Prevention Clinic at St. Paul’s Hospital in Vancouver. Dr. Brunham is the Principal Investigator of the BC Familial Hypercholesterolemia Registry and leads a research team at the UBC Centre for Heart Lung Innovation that focuses on inherited lipid disorders and premature coronary artery disease.
>> View the video
Do you have questions about this interview? Ask your question in the VESL community on Sosido
Forgot your password?
You can instantly reset your password
The VESL community is designed for the scientific exchange of information between Healthcare Professionals and is made possible with financial support from Novartis Canada. Novartis does not itself monitor the discussions. However a third-party service provider does review the discussions only for the purpose of identifying any potential AE discussion. This review is required since as a drug manufacturer, Novartis has a regulatory obligation to report any AE that (directly or indirectly) comes to their attention. The third-party will only report the potential AE discussion and will include contact information. Should your post be reported to patient safety, you will be contacted by the third-party service provider to determine if you would like Novartis patient safety to contact you for more details.